Cell Research (2006) 16: 25–30. doi:10.1038/sj.cr.7310005; published online 16 January 2006
Due to concerns regarding the overlapping figures in this review that are identical to those contained in a review article that we have co-authored and published earlier, we retract the above paper we published in Cell Research. We apologize for any confusion that may be caused by this matter, although we stand by the scientific contents contained in the Cell Research paper.
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/sj.cr.7310005
About this article
Cite this article
Liu, X., Gu, J. Retraction Note to: Targeting gene-virotherapy of cancer. Cell Res 16, 740 (2006). https://doi.org/10.1038/sj.cr.7310088
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cr.7310088
This article is cited by
-
GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo
Acta Pharmacologica Sinica (2018)
-
Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion
British Journal of Cancer (2014)
-
A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis
Tumor Biology (2013)
